Bridge Between Neuroimmunity and Traumatic Brain Injury
Year: 2013
Type: article
Abstract: The pathophysiology of degenerative, infectious, inflammatory and traumatic diseases of the central nervous system includes a significant immune component. As to the latter, damage to the cerebral vasculature and neural cell bodies, caused by traumatic brain injury (TBI) activates innate immunity with concomitant infiltration of immunocytes into the damaged nervous system. This leads to proinflammatory cytokine and prostaglandin production and lost synaptic integrity and more generalized neurotoxicity. Engagement of adaptive immune responses follows including the production of antibodies and lymphocyte proliferation. These affect the tempo of disease along with tissue repair and as such provide a number of potential targets for pharmacological treatments for TBI. However, despite a large body of research, no such treatment intervention is currently available. In this review we will discuss the immune response initiated following brain injuries, drawing on knowledge gained from a broad array of experimental and clinical studies. Our discussion seeks to address potential therapeutic targets and propose ways in which the immune system can be controlled to promote neuroprotection.
Source: Current Pharmaceutical Design
Authors: Matthew L. Kelso, Howard E. Gendelman
Institution: University of Nebraska Medical Center
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence, Nanomedicine and NeuroAIDS, Novel Adjunctive Therapies for NeuroAIDS, Molecular Mechanisms of HIV-1 Associated Encephalopathy, Nebraska Center for Nanomedicine, SMART HAND, Neural Immunity in HIV Dementia, Neuroprotective Immunity and HIV Dementia
OpenAlex ID: W2076704068
